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1158Abstract: Little is known about how far opioid shoppers travel or how often they cross state lines to
fill their opioid prescriptions. This retrospective cohort study evaluated these measures for opioid
shoppers and nonshoppers using a large U.S. prescription database. Patients with $3 opioid dispens-
ings were followed for 18 months. A subject was considered a shopper when he or she filled
overlapping opioid prescriptions written by >1 prescriber at $3 pharmacies. A heavy shopper had
$5 shopping episodes. Outcomes assessed were distance traveled among pharmacies and number
of states visited to fill opioid prescriptions. A total of 10,910,451 subjects were included; .7% devel-
oped any shopping behavior and their prescriptions accounted for 8.6% of all opioid dispensings.
Shoppers and heavy shoppers were younger than the nonshoppers. Shoppers traveled a median
of 83.8 miles, heavy shoppers 199.5 miles, and nonshoppers 0 miles. Almost 20% of shoppers or
heavy shoppers, but only 4% of nonshoppers, visited >1 state. Shoppers traveled greater distances
and more often crossed state borders to fill opioid prescriptions than nonshoppers, and their dispens-
ings accounted for a disproportionate number of opioid dispensings. Sharing of data among
prescription-monitoring programs will likely strengthen those programs and may decrease shopping
behavior.
Perspective: This study shows that opioid shoppers travel greater distances and more often cross
state borders to fill opioid prescriptions than nonshoppers, and their dispensings accounted for a
disproportionate number of opioid dispensings. The findings support the need for data sharing
among prescription-monitoring programs to deter opioid shopping behavior.
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btaining opioid prescriptions from multiple pre-
scribers, known as opioid shopping, is an impor-
tant method of abusing or diverting opioids2
and is a subject of increased study. Relative to those
subjects without shopping behavior, subjects with
shopping behavior more often fill prescriptions for
schedule II opioids, less often fill prescriptions for
opioid combination products, and more often pay in
cash.3 Each shopper obtains prescriptions from a rela-
tively small number of prescribers (typically #4 pre-
scribers),3 and the top quartile of opioid prescribers
(those with more than 65 patients in their practiceFebruary 1, 2013; Revised April 23, 2013; Accepted April 24,
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of all shoppers.1 It is also recognized that the risk of
opioid shopping varies with age3,12 and the type of
opioid.4
At present, 43 states use prescription-monitoring pro-
grams to identify and deter or prevent drug abuse
and diversion and opioid shopping.8,10 These programs
are based on statewide electronic databases that
collect data on opioids and other controlled substances
dispensed in the state; although data sharing across
states is increasing, it remains far froma commonpractice.
Little is known about how far opioid shoppers travel or
how often they cross state lines to fill their opioid
prescriptions. Therefore, the objective of this study was
to evaluate these measures for opioid shoppers
compared with nonshoppers.Methods
We conducted a retrospective cohort study using an
IMS LRx, a large U.S. retail prescription database.
This longitudinal database covers 65% of all retail
Cepeda et al The Journal of Pain 1159dispensing in the United States and includes all types of
pharmacies—chains, food stores, mass merchandisers,
and independent stores. From each of the pharmacies
in the panel, the database captures all prescriptions
dispensed, regardless of payment type (including cash
transactions). The LRx database contains deidentified
data on the subject, the pharmacy and its geographic
coordinates, and the prescriber. To uniquely identify a
subject who filled prescriptions at multiple pharmacies,
a probabilistic multilevel match is performed using a pro-
prietary algorithm–based on encrypted, nonidentifiable
data elements that include gender, date of birth, last
name, first name, address, city, state, zip code, and payer.
The algorithm is designed to allow for matching in an
environment where there is potential for typographical
data entry error and inconsistencies while at the same
time limiting the number of false positives. Thematching
is probabilistic because it uses algorithms and statistical
analysis to determine the likelihood that 2 recordsmatch.
It is multilevel because it has multiple steps. The first step
looks for an exact match on all variables. In subsequent
steps, 1 variable at a time is excluded, but the algorithm
still requires exact matching on all other variables.
Inclusion Criteria
Subjects with $3 opioid dispensings (the minimum
number a shopper could have; see definition below)
for any type of opioid in 2008 and 18 months of
follow-up time in the database were included. Each
subject was followed for 18 months from the index
dispensing (the first opioid dispensing in 2008). Shop-
ping behavior was defined as a subject filling opioid
prescriptions written by >1 prescriber with $1 day of
overlap at $3 pharmacies. Heavy shopping behavior
was defined as a subject’s having $5 shopping
episodes in the 18 months of follow-up. Such a number
of shopping episodes represents unusually heavy
shopping inasmuch as 90% of subjects with shopping
behavior had fewer than 5 shopping episodes.3 This
definition of shopping behavior has been used in previ-Table 1. Characteristics of Nonshoppers and Shopp
Involved in Filling Opioid Prescriptions
NONS
Subjects with $3 opioid dispensings, n (row %) 10,835,2
Age (mean 6 SD), y 50.6 6 1
Men (%) 4,046,4
Women (%) 6,729,5
Number of opioid dispensings (median [25th–75th])
Distance traveled (median [25th–75th]), miles
Maximum distance traveled (median [25th–75th]), miles
Number of states visited, n (column %)
1 10,380,2
2 427,9
3 24,4
4 2,1
$5 4
Abbreviation: SD, standard deviation.
*Subjects who filled opioid prescriptions written by >1 prescriber with $1 day of ov
ySubjects with $5 shopping episodes in the 18 months of follow-up.ous research and distinguishes opioids from diuretics.
Subjects exposed to diuretics exhibited lower frequency
of shopping behavior (0.03%) than subjects exposed to
opioids (0.18%).1-4
Distance Calculation
The outcomes assessed were each subject’s distance
traveled and the number of states visited to fill opioid
prescriptions.
Subjects were classified into 3 exclusive categories:
nonshopper, shopper, or heavy shopper. Then, all pharma-
cies the subject visited tofill theopioid prescriptions during
the 18 months of follow-up were used to calculate the
distances traveled. For this calculation, we used the
pharmacies’ geographic coordinates. Two distances are
reported for the18-month follow-upperiod: the totalmiles
traveled among pharmacies during the 18-month period
and the maximum miles traveled among pharmacies. To
calculatethetotalmiles traveled, thedistancesamongphar-
macies were summed, and the chronological order of the
pharmacy visits was taken into account. When the visits to
thepharmaciesoccurredon the sameday, thedistance trav-
eled was calculated simply by sorting the zip codes of the
pharmacies from lowest to highest and then calculating
the distances in that order. To calculate the maximum
distance among a collection of pharmacies, we calculated
all of the pairwise distances and selected the largest. If the
subject visited the samepharmacy, thedistancewas set to0.
In addition, the number of states visited during the
follow-up period was determined. Median distances
and the 25th and 75th percentiles are reported.Results
A total of 10,910,451 subjects had $3 opioid dispens-
ings; of these subjects, .7% developed any shopping
behavior (0.6% developed shopping behavior and .1%
developed heavy shopping behavior); see Table 1.
Shoppers and heavy shoppers were younger than
the nonshoppers (Table 1). Compared with theers, Distance Traveled and Number of States
HOPPERS SHOPPERS* HEAVY SHOPPERSy
36 (99.3) 65,780 (0.6) 9,435 (0.1)
7.9 45.2 6 13.4 45.6 6 12.0
35 (99.2) 27,456 (0.7) 4,158 (0.08)
37 (99.4) 38,262 (0.6) 5,265 (0.1)
6 (4–13) 39 (24–72) 390 (250–710)
0 (0–4.3) 83.8 (34.5–287.1) 199.5 (88.2–651.6)
0 (0–2.6) 12.6 (5.6–47.4) 15 (6.9–77)
83 (95.8) 53,071 (80.7) 7,321 (77.6)
48 (3.9) 10,620 (16.1) 1,612 (17.1)
19 (0.2) 1,730 (2.6) 375 (4.0)
66 (0.02) 279 (0.4) 100 (1.1)
20 (0.0) 80 (0.12) 27 (0.29)
erlap at $3 pharmacies.
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shoppers, and especially for heavy shoppers, were
much higher (Table 1). Of the 119,852,870 opioid
prescriptions dispensed, 91.4% were dispensed to
nonshoppers, 3.1% to shoppers, and 5.5% to heavy
shoppers.
Shoppers and heavy shoppers traveled greater dis-
tances to fill opioid prescriptions than nonshoppers.
Shoppers traveled a median of 83.8 miles, heavy shop-
pers a median of 199.5 miles, and nonshoppers a median
of 0 miles. The maximum distance traveled followed a
similar pattern (Table 1).
Almost 20% of the shoppers or heavy shoppers visited
>1 state to fill opioid prescriptions, but only 4% of
nonshoppers visited >1 state (Table 1).
When analyses were restricted to subjects with the
same number of dispensings, it remained true that heavy
shoppers traveled farther than shoppers, and shoppers
traveled farther than nonshoppers. Similarly, shoppers
and heavy shoppers had opioid dispensings in more
states than nonshoppers. For example, for subjects with
10 dispensings, shoppers traveled a median of 37.6 miles
(25th–75th, 16.5–135.4) and nonshoppers traveled a
median of 0 miles (25th–75th, 0–6.1).
Discussion
This population-based study includedalmost 11million
subjects exposed to opioids, and the results indicate that
shoppers and heavy shoppers travel greater distances
and cross state lines more often than nonshoppers.
The study may underestimate the prevalence of
shopping behavior, the distance traveled, and the
proportion of subjects who crossed state lines.
LRx database does not have 100% coverage of all
pharmacy transactions in the United States. Moreover,
the probabilistic matching algorithm used to uniquely
identify subjects could fail to identify 2 subjects as the
same individual if a minimum number of required
encrypted attributes do not match or could fail todiscern a subject who presented false identification.
However, no other data source will permit an assess-
ment in the whole country or will capture cash
prescriptions, which are very relevant when evaluating
opioid shopping behavior.
We found that those exhibiting any type of shopping
behavior filled substantially more opioid prescriptions
per subject than nonshoppers. Shoppers obtained
a median of 39 dispensings, and heavy shoppers
obtained a median of 390 dispensings in the 18 months
of observation. Therefore, it is not surprising that
shoppers’ and heavy shoppers’ dispensings account
for 8.6% of the total number of opioid dispensings
despite the fact that, together, they represent only
.7% of the subjects.
Shoppers often filled their opioid prescriptions in mul-
tiple states, suggesting that these subjects obtain their
opioid prescriptions from prescribers in multiple states.
Until 2011, state prescription-monitoring programs did
not share data between states.5,9 Currently, 10 states
share prescription-monitoring data, and it is expected
that such interstate data sharingwill becomemorewide-
spread,5,9 which could permit the identification of
subjects with shopping behavior. However, there are
some states that do not have prescription-monitoring
programs in place and may never find the funding to
do so, and others in which participation is optional, so
for these programs to be truly effective they would
need to evolve into a federal program or into shared
state–federal prescription-monitoring programs.6
Though inconsistent,7 there is some evidence that
prescription-monitoring programs decrease opioid
diversion8,13 and that opioid shopping behavior has
been associated with opioid-related death.11 The find-
ings of the present study suggest that effective data
sharing among prescription-monitoring programs may
improve these programs’ effectiveness in deterring
opioid shopping behavior and may even decrease
opioid-related deaths.References
1. Cepeda MS, Fife D, Berlin JA, Mastrogiovanni G, Yuan Y:
Characteristics of prescribers whose patients shop for opioids:
Results from a cohort study. J Opioid Manag 8:285-291, 2012
2. Cepeda MS, Fife D, Chow W, Mastrogiovanni G,
Henderson SC: Assessing opioid shopping behaviour: A large
cohort study from a medication dispensing database in the
US. Drug Saf 35:325-334, 2012
3. Cepeda MS, Fife D, Chow W, Mastrogiovanni G,
Henderson SC: Opioid shopping behavior: How often, how
soon, which drugs, and what payment method. J Clin
Pharmacol, 2012
4. Cepeda MS, Fife D, Vo L, Mastrogiovanni G, Yuan Y:
Comparison of opioid doctor shopping for tapentadol and
oxycodone: A cohort study. J Pain 14:158-164, 2013
5. Fass JA, Hardigan PC: Attitudes of Florida pharmacists
toward implementing a state prescription drug monitoring
program for controlled substances. J Manag Care Pharm
17:430-438, 20116. Finklea K, Bagalman E, Sacco L: Prescription drug moni-
toring programs. Congressional Research Service 2013.
Available at: http://www.fas.org/sgp/crs/misc/R42593.pdf
7. Gilson AM, Fishman SM, Wilsey BL, Casamalhuapa C,
Baxi H: Time series analysis of California’s prescription
monitoring program: Impact on prescribing and multiple
provider episodes. J Pain 13:103-111, 2012
8. MorganL,WeaverM,SayeedZ,OrrR:Theuseofprescription
monitoring programs to reduce opioid diversion and improve
patient safety. J Pain Palliat Care Pharmacother 27:4-9, 2013
9. National Association of Boards of Pharmacy: NABP PMP
InterConnect. Available at: http://www.nabp.net/programs/
pmp-interconnect/nabp-pmp-interconnect. Accessed April
1, 2013
10. Office of Diversion Control: State prescription drug
monitoring programs. Available at: http://www.deadi
version.usdoj.gov/faq/rx_monitor.htm
11. Peirce GL, Smith MJ, Abate MA, Halverson J: Doctor and
pharmacy shopping for controlled substances. Med Care 50:
494-500, 2012
Cepeda et al The Journal of Pain 116112. Wilsey BL, Fishman SM, Gilson AM, Casamalhuapa C,
Baxi H, Zhang H, Li CS: Profiling multiple provider prescrib-
ing of opioids, benzodiazepines, stimulants, and anorectics.
Drug Alcohol Depend 112:99-106, 201013. Worley J: Prescription drug monitoring programs, a
response to doctor shopping: Purpose, effectiveness, and
directions for future research. Issues Ment Health Nurs 33:
319-328, 2012
